World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
32976
World Ranking
7750
National Ranking
758

Overview

Nigel Heaton is affiliated with King's College London in the United Kingdom. Their research primarily focuses on medicine with significant contributions in surgery, hepatology, epidemiology, transplantation, and oncology.

The scientist's work centers on organ transplantation techniques and outcomes, liver disease and transplantation, liver disease diagnosis and treatment, renal transplantation outcomes and treatments, hepatocellular carcinoma treatment and prognosis, organ donation and transplantation, and cholangiocarcinoma and gallbladder cancer studies.

Frequent coauthors collaborating with Nigel Heaton include Yoh Zen, Wayel Jassem, Andreas Prachalias, Rosa Miquel, and Abid Suddle.

Nigel Heaton has published extensively in leading academic venues. The most frequent publication sources include the Journal of Hepatology, HPB, Transplantation, American Journal of Transplantation, and Liver Transplantation.

Selected recent papers authored or coauthored by Nigel Heaton cover a range of topics related to liver transplantation and outcomes:

  • Hypothermic Machine Perfusion in Liver Transplantation - A Randomized Trial (2021), New England Journal of Medicine
  • A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation (2023), Journal of Hepatology
  • Liver transplantation for critically ill cirrhotic patients: Stratifying utility based on pretransplant factors (2020), American Journal of Transplantation
  • A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation (2021), Journal of Hepatology
  • Utilization of livers donated after circulatory death for transplantation - An international comparison (2023), Journal of Hepatology

Best Publications

  • A randomized trial of normothermic preservation in liver transplantation

    David Nasralla;Constantin C Coussios;Hynek Mergental;M Zeeshan Akhtar

  • Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients.

    Carlos Paya;Atul Humar;Ed Dominguez;Kenneth Washburn

  • Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update

    Shahid A Khan;Brian R Davidson;Robert D Goldin;Nigel Heaton

  • De-novo autoimmune hepatitis after liver transplantation

    Nanda Kerkar;Nedim Hadzic;Edward T Davies;Bernard Portmann

  • Liver Transplantation After Ex Vivo Normothermic Machine Preservation: A Phase 1 (First-in-Man) Clinical Trial

    R. Ravikumar;W. Jassem;H. Mergental;N. Heaton

  • Lessons from look-back in acute liver failure? A single centre experience of 3300 patients.

    William Bernal;Anna Hyyrylainen;Amit Gera;Vinod K. Audimoolam

  • Hypothermic Machine Perfusion in Liver Transplantation — A Randomized Trial

    Rianne van Rijn;Ivo J. Schurink;Yvonne de Vries;Aad P. van den Berg

  • Prevalence of the Activating JAK2 Tyrosine Kinase Mutation V617F in the Budd-Chiari Syndrome

    Raj K. Patel;Nicholas C. Lea;Michael A. Heneghan;Nigel B. Westwood

  • Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?

    Bo Göran Ericzon;Henryk E. Wilczek;Marie Larsson;Priyantha Wijayatunga

  • Survival of Human Immunodeficiency Virus–Infected Liver Transplant Recipients

    Margaret V. Ragni;Steven H. Belle;KyungAh Im;Guy Neff

  • Hepatocyte transplantation for inherited factor VII deficiency.

    Anil Dhawan;Ragai R. Mitry;Robin D. Hughes;Sharon Lehec

  • The role of mitochondria in ischemia/reperfusion injury.

    Wayel Jassem;Susan V Fuggle;Mohamed Rela;Dicken D H Koo

  • Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans.

    Charalambos Gustav Antoniades;Charalambos Gustav Antoniades;Alberto Quaglia;Leonie S. Taams;Ragai R. Mitry

  • Patients With Acute-on-Chronic Liver Failure Have Increased Numbers of Regulatory Immune Cells Expressing the Receptor Tyrosine Kinase MERTK

    Christine Bernsmeier;Oltin T. Pop;Arjuna Singanayagam;Evangelos Triantafyllou;Evangelos Triantafyllou

  • Absence of Cytomegalovirus-Resistance Mutations after Valganciclovir Prophylaxis, in a Prospective Multicenter Study of Solid-Organ Transplant Recipients

    Guy Boivin;Nathalie Goyette;Christian Gilbert;Noel Roberts

  • Pharmacodynamics of oral ganciclovir and valganciclovir in solid organ transplant recipients.

    Hugh Wiltshire;Carlos V. Paya;Mark D. Pescovitz;Atul Humar

  • Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation.

    Arie J Stangou;Nigel D Heaton;Philip N Hawkins

  • Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease.

    Andrew D. Yeoman;Rachel H. Westbrook;Thawab Al-Chalabi;Ivana Carey

  • Use and outcome of liver transplantation in acetaminophen‐induced acute liver failure

    William Bernal;Julia Wendon;Mohamed Rela;Nigel Heaton

  • Prevalence of the Activating JAK2 Tyrosine Kinase Mutation V617F in the Budd-Chiari Syndrome.

    Raj K. Patel;Nicholas Lea;Michael A. Heneghan;Nigel Westwood

Frequent Co-Authors

Anil Dhawan
Anil Dhawan King's College London
John O'Grady
John O'Grady King's College London
Julia Wendon
Julia Wendon King's College London
Giorgina Mieli-Vergani
Giorgina Mieli-Vergani King's College London
Bernard Portmann
Bernard Portmann King's College London
Roger Williams
Roger Williams Foundation for Liver Research
Yoh Zen
Yoh Zen King's College London
Yun Ma
Yun Ma King's College London
Ghulam J. Mufti
Ghulam J. Mufti King's College London
Diego Vergani
Diego Vergani King's College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a medical career in the USA offers more than just the traditional MD route. There are numerous alternative pathways and online degrees designed for flexibility and speed. For nurses aiming to advance, exploring rn to bsn online no clinicals programs can be ideal, especially for those balancing work and study. These programs eliminate the requirement for in-person clinicals, making it easier for working nurses to upskill entirely online.

Advanced degrees like the Doctor of Nursing Practice (DNP) are now more accessible through fully online options. The online dnp programs provide a flexible approach for nurses who want to reach leadership or specialized roles. Some universities even offer accelerated paths, such as a 1 year dnp program online, helping you fast-track your qualifications.

Those just starting their healthcare journey might benefit from fast track medical lpn programs. These online options offer the opportunity to enter the workforce quickly and begin gaining practical experience. Whether advancing your current career or entering the healthcare field, online medical degrees open up accessible and diverse pathways.

Best Scientists Citing Nigel Heaton

Trending Scientists

Recently Published Articles